Contrarian Sales Techniques

FEBRUARY 29, 2024

Are your interest piqued by the words ‘pharmaceutical sales’? Let’s look at the exciting possibilities, essential skills, and valuable resources that can prepare you for success with the entry-level pharmaceutical sales. Internships: While less common than seeking full-time jobs, this could still be a possible intent.

Sales 52

Sales Pharmaceutical Sales Pharma Networking 52

European Pharmaceutical Review

OCTOBER 24, 2023

Europe’s position in the global pharmaceutical packaging and labelling market The authors highlighted that Europe led the worldwide market at 27 percent in 2022. percent in 2022.

Pharmaceutical 96

Pharmaceutical Marketing Medicine Pharmaceutical Sales 96

Evolve Your Success

JANUARY 31, 2023

In this episode, Samuel Adeyinka interviews John Crowder who covers how to sell effectively in medical sales. Tune in now and get medical sales-ready! — Watch the episode here Listen to the podcast here Selling Effectively In Medical Sales With John Crowder We have with us another special guest. I’m wonderful.

Medical sales 64

Medical sales Sales Medical Training 64

Pharmaceutical Technology

JANUARY 30, 2023

The UK government’s decision to set an unprecedented payback rate of 26.5% on National Health Service (NHS) sales of branded medicines in 2023, almost double that of the previous year, has sent shock waves through the pharma industry. Calculations behind the jump in payback rate The government-calculated 2023 clawback level of 26.5%

Government 97

Government Pharma Sales Medicine 97

Evolve Your Success

MAY 16, 2023

I have a big playlist of medical sales, medical information, news and innovation. While I was there, I met the hospice world, hospice sales and the ins and outs of hospice care. I remember back in my pharmaceutical sales rep days and I’m talking as far as 2009 or 2010. This is a whole new thing for you?

Medical sales 52

Medical sales Sales Medical Doctors 52

Pharmaceutical Technology

JULY 23, 2008

It has boosted anti-tumour research by 60% since 2005, at a cost of $1.6bn, in the hope of increasing the share of company sales attributed to cancer drugs from the current level of 5% “There are a lot of patients that are suffering,” said Pfizer chief executive Jeffrey Kindler. So what’s driving the growth? .

Side effects 52

Side effects Marketing Pharmaceutical Sales 52